New pill could tame lung inflammation in sarcoidosis
Disease control
Recruiting now
This Phase 2 trial tests OATD-01, an oral drug that blocks a protein called chitinase-1, in 96 people with active pulmonary sarcoidosis. Participants take the drug or a placebo for 12 weeks to see if it reduces lung inflammation measured by PET scans. The goal is to find a new tr…
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC